Clinical Trial Update: An Efficacy and Safety Study for Nesiritide in Heart Failure Patients With Reduced Kidney Function Undergoing Coronary Artery Bypass Graft Surgery Requiring Cardiopulmonary Bypass (CPB Pump or Heart Lung Machine) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating nesiritide in heart failure patients with reduced kidney function undergoing coronary artery bypass graft surgery requiring cardiopul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Heart Failure
• Ischemic Heart Disease

Drugs mentioned

• Nesiritide (recombinant human B-type natriuretic peptide (rhBNP))

Snippet

Sponsor: Scios, Inc. | Conditions: Coronary Artery Bypass Surgery, Coronary Heart Disease | Phase 3 | Status: WITHDRAWN